Welcome to BioMarin's Online Press Room.
We've brought together a variety of information in one location
to better assist you in your efforts to research and develop
news articles. Should you require additional information, please
call or e-mail us any time.
Sarah Cannon Research Institute UK and BioMarin Collaborate on EMBRACA Clinical Study in Hereditary Breast Cancer With BRCA Mutation... MORE >BioMarin to Host Second Quarter 2014 Financial Results Conference Call and Webcast on Wednesday, July 30 at 4:30pm ET... MORE >BioMarin Announces Health Canada Approval of VIMIZIM™ (elosulfase alfa) for the Treatment of Morquio A Syndrome... MORE >